4//SEC Filing
Finn Jonathan 4
Accession 0000950170-24-043690
CIK 0001488039other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:05 PM ET
Size
4.9 KB
Accession
0000950170-24-043690
Insider Transaction Report
Form 4
Finn Jonathan
Director
Transactions
- Purchase
Common Stock
2024-04-10$1.77/sh+25,000$44,250→ 25,000 total
Footnotes (1)
- [F1]The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $1.74 to $1.78. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, The Reporting Person will provide full information regarding the number of shares purchased at each separate price.
Documents
Issuer
ATOSSA THERAPEUTICS, INC.
CIK 0001488039
Entity typeother
Related Parties
1- filerCIK 0001981595
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:05 PM ET
- Size
- 4.9 KB